Praxilene

Nafronyl A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.

Molecular Formula: C₂₆H₃₅NO₇

InChI: InChI=1/C24H33NO3.C2H2O4/c1-3-25(4-2)14-16-28-24(26)21(18-22-12-8-15-27-22)17-20-11-7-10-19-9-5-6-13-23(19)20;3-1(4)2(5)6/h5-7,9-11,13,21-22H,3-4,8,12,14-18H2,1-2H3;(H,3,4)(H,5,6)/fC24H34NO3.C2HO4/h25H;3H/q+1;-1

InChIKey: InChIKey=SSAJNPNVUYMUCI-MWAQAAFSCP
SMILES: CC[NH+](CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32.C(=O)(C(=O)[O-])O

Names:
    diethyl-[2-[2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoyl]oxyethyl]azanium; 2-hydroxy-2-oxo-acetate
    Dubimax
    Dusodril
    Gevatran
    Iridus
    Nafronyl acid oxalate
    Nafronyl oxalate [USAN]
    Nafronyl oxalate
    Naftidrofuryl oxalate
    Naphtidrofuryl oxalate
    Praxilene

Registries:
    PubChem CID 18542
    PubChem ID 161558